Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR-CAP vs R-CHOP in Newly Diagnosed Non-GCB DLBCL
NCT01040871Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in diffuse large B-cell lymphoma (DLBCL), sponsored by Millennium Pharmaceuticals. Started Jan 2010; status: completed.
02
Drugs
bortezomib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01040871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040871.